{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:35:19Z","timestamp":1790062519135,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Neurophyxia BV"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40272-019-00373-3","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T03:02:46Z","timestamp":1579575766000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Phase IIa Clinical Trial of 2-Iminobiotin for the Treatment of Birth Asphyxia in DR Congo, a Low-Income Country"],"prefix":"10.1007","volume":"22","author":[{"given":"Th\u00e9r\u00e8se","family":"Biselele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jepht\u00e9","family":"Bambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu M.","family":"Betukumesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoly","family":"Ndiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Tabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Kapinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Makaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibert","family":"Tjabbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6868","authenticated-orcid":false,"given":"Cacha","family":"Peeters-Scholte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"373_CR1","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation. In: Levels and trends in child mortality. Report 2018. https:\/\/data.unicef.org\/wp-content\/uploads\/2018\/10\/Child-Mortality-Report-2018.pdf. Accessed 13 Nov 2019."},{"issue":"Suppl 1","key":"373_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2393-10-S1-S1","volume":"10","author":"JE Lawn","year":"2010","unstructured":"Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C, Group GR. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10(Suppl 1):S1.","journal-title":"BMC Pregnancy Childbirth."},{"issue":"3","key":"373_CR3","doi-asserted-by":"publisher","first-page":"e58834","DOI":"10.1371\/journal.pone.0058834","volume":"8","author":"SS Pauliah","year":"2013","unstructured":"Pauliah SS, Shankaran S, Wade A, Cady EB, Thayyil S. Therapeutic hypothermia for neonatal encephalopathy in low- and middle-income countries: a systematic review and meta-analysis. PLoS One. 2013;8(3):e58834.","journal-title":"PLoS One."},{"issue":"123","key":"373_CR4","first-page":"131","volume":"142","author":"M Albrecht","year":"2019","unstructured":"Albrecht M, Zitta K, Groenendaal F, van Bel F, Peeters-Scholte C. Neuroprotective strategies following perinatal hypoxia-ischemia: taking aim at NOS. Free Radic Biol Med. 2019;142:123\u201331.","journal-title":"Free Radic Biol Med."},{"issue":"9","key":"373_CR5","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1161\/01.STR.0000028343.25901.09","volume":"33","author":"C Peeters-Scholte","year":"2002","unstructured":"Peeters-Scholte C, Koster J, Veldhuis W, van den Tweel E, Zhu C, Kops N, et al. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke. 2002;33(9):2304\u201310.","journal-title":"Stroke."},{"issue":"3","key":"373_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1161\/STROKEAHA.112.677922","volume":"44","author":"ST Bjorkman","year":"2013","unstructured":"Bjorkman ST, Ireland Z, Fan X, van der Wal WM, Roes KC, Colditz PB, et al. Short-term dose-response characteristics of 2-iminobiotin immediately postinsult in the neonatal piglet after hypoxia-ischemia. Stroke. 2013;44(3):809\u201311.","journal-title":"Stroke."},{"issue":"1","key":"373_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/sj.jcbfm.9600007","volume":"25","author":"ER van den Tweel","year":"2005","unstructured":"van den Tweel ER, van Bel F, Kavelaars A, Peeters-Scholte CM, Haumann J, Nijboer CH, et al. Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats. J Cereb Blood Flow Metab. 2005;25(1):67\u201374.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"2","key":"373_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.jcbfm.9600342","volume":"27","author":"CH Nijboer","year":"2007","unstructured":"Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ. Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab. 2007;27(2):282\u201392.","journal-title":"J Cereb Blood Flow Metab."},{"key":"373_CR9","unstructured":"Neurophyxia. In: Literature: phase 1 clinical study: first-in-man 2-IB dose escalation study. https:\/\/www.neurophyxia.com\/files\/results-phase1-clinical-trial.pdf. Accessed 13 Nov 2019."},{"key":"373_CR10","unstructured":"Neurophyxia. In: Literature: determination of target dose for phase II study of 2-iminobiotin (2-IB) in neonates with perinatal asphyxia. https:\/\/www.neurophyxia.com\/files\/2012-01-18-Determination-of-target-dose-for-Phase-II.pdf. Accessed 13 Nov 2019."},{"key":"373_CR11","unstructured":"https:\/\/www.clinicaltrialsregister.eu. Accessed 13 Nov 2019. Eudra CT number 2011-002502-74."},{"key":"373_CR12","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/jps.23574","volume":"102","author":"N Holford","year":"2013","unstructured":"Holford N, Heo Y-A, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013;102:2941\u201352.","journal-title":"J Pharm Sci"},{"key":"373_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0587-1","author":"LMA Favi\u00e9","year":"2019","unstructured":"Favi\u00e9 LMA, Peeters-Scholte CMPCD, Bakker A, Tjabbes H, Egberts TCG, van Bel F, Rademaker CMA, Vis P, Groenendaal F. Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia. Pediatr Res. 2019. https:\/\/doi.org\/10.1038\/s41390-019-0587-1.","journal-title":"Pediatr Res"},{"key":"373_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1651-2227.1997.tb08581.x","volume":"86","author":"CM Thompson","year":"1997","unstructured":"Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno CD, Malan AF. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997;86:757\u201361.","journal-title":"Acta Paediatr."},{"key":"373_CR15","volume-title":"NONMEM user\u2019s guides (1989\u20132011)","author":"S Beal","year":"2011","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM user\u2019s guides (1989\u20132011). Ellicott City: Icon Development Solutions; 2011."},{"issue":"6","key":"373_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.siny.2006.07.011","volume":"11","author":"L Hellstr\u00f6m-Westas","year":"2006","unstructured":"Hellstr\u00f6m-Westas L, Ros\u00e9n I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med. 2006;11(6):503\u201311.","journal-title":"Semin Fetal Neonatal Med."},{"issue":"3","key":"373_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.siny.2018.02.003","volume":"23","author":"L Hellstr\u00f6m-Westas","year":"2018","unstructured":"Hellstr\u00f6m-Westas L. Amplitude-integrated electroencephalography for seizure detection in newborn infants. Semin Fetal Neonatal Med. 2018;23(3):175\u201382.","journal-title":"Semin Fetal Neonatal Med."},{"issue":"8","key":"373_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/apa.14263","volume":"107","author":"T Biselele","year":"2018","unstructured":"Biselele T, Bambi J, Naulaers G, Tabu G, Kapinga J, Bola V, et al. Observational study shows that it is feasible to provide neuroprotective treatment for neonatal encephalopathy in low-income countries. Acta Paediatr. 2018;107(8):1345\u20139.","journal-title":"Acta Paediatr."},{"key":"373_CR19","first-page":"CD003311","volume":"1","author":"SE Jacobs","year":"2013","unstructured":"Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;1:CD003311.","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"373_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.siny.2014.10.004","volume":"20","author":"P Montaldo","year":"2015","unstructured":"Montaldo P, Pauliah SS, Lally PJ, Olson L, Thayyil S. Cooling in a low-resource environment: lost in translation. Semin Fetal Neonatal Med. 2015;20(2):72\u20139.","journal-title":"Semin Fetal Neonatal Med."},{"key":"373_CR21","unstructured":"IHME. Global burden of disease. https:\/\/vizhub.healthdata.org\/gbd-compare\/. Accessed 7 Nov 2019."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00373-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T01:15:12Z","timestamp":1611105312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00373-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00373-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"21 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by Neurophyxia BV.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors T. Biselele, J. Bambi, D. Betukumesu, Y. Ndiyo, G. Tabu, J. Kapinga, V. Bola, P. Makaya, and P. Vis have no disclosures. Authors H. Tjabbes and C. Peeters-Scholte are co-founders, consultants for and shareholder of Neurophyxia BV. Author H. Tjabbes is Vice-President Regulatory and Medical Affairs of Neurophyxia, and author C. Peeters-Scholte is Chief Scientific Officer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethical committee of the Public Health School of the University of Kinshasa (DR Congo) and the ethical committee of the University of Utrecht (The Netherlands), and in line with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from one of the parents in local language (Lingala) or French before start of the study. When the consenting parent was illiterate, informed consent was given verbally in the presence of an impartial witness.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}